Selected research
Market Structure
Global Donepezil Hydrochloride Tablet Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Donepezil Hydrochloride Tablet market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Donepezil Hydrochloride Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Donepezil Hydrochloride Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Donepezil Hydrochloride Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Donepezil Hydrochloride Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Donepezil Hydrochloride Tablet include Eisai, Luoxin Pharmaceutical, Pfizer, Huahai Pharmaceutical, Hansoh Pharma, Hisun Pharmaceutical, ARK PHA.LTD, Lupin and Globalstar, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Donepezil Hydrochloride Tablet market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Donepezil Hydrochloride Tablet and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Donepezil Hydrochloride Tablet sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Donepezil Hydrochloride Tablet market size, projected growth trends, production technologies, key applications, and end-use industries.
Donepezil Hydrochloride Tablet Segment by Company
Eisai
Luoxin Pharmaceutical
Pfizer
Huahai Pharmaceutical
Hansoh Pharma
Hisun Pharmaceutical
ARK PHA.LTD
Lupin
Globalstar
G Med Impex
Donepezil Hydrochloride Tablet Segment by Type
5 mg/tablet
10 mg/tablet
Donepezil Hydrochloride Tablet Segment by Application
Hospitals
Drugstores
Others
Donepezil Hydrochloride Tablet Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Donepezil Hydrochloride Tablet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Donepezil Hydrochloride Tablet and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Donepezil Hydrochloride Tablet.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Donepezil Hydrochloride Tablet market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Donepezil Hydrochloride Tablet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Donepezil Hydrochloride Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Donepezil Hydrochloride Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 5 mg/tablet
- 10 mg/tablet
Applications
- Hospitals
- Drugstores
- Others
Companies covered
- Eisai
- Luoxin Pharmaceutical
- Pfizer
- Huahai Pharmaceutical
- Hansoh Pharma
- Hisun Pharmaceutical
- ARK PHA.LTD
- Lupin
- Globalstar
- G Med Impex
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Donepezil Hydrochloride Tablet Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Donepezil Hydrochloride Tablet Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Donepezil Hydrochloride Tablet Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Donepezil Hydrochloride Tablet Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Donepezil Hydrochloride Tablet Market Dynamics
- 2.1 Donepezil Hydrochloride Tablet Industry Trends
- 2.2 Donepezil Hydrochloride Tablet Industry Drivers
- 2.3 Donepezil Hydrochloride Tablet Industry Opportunities and Challenges
- 2.4 Donepezil Hydrochloride Tablet Industry Restraints
3 Donepezil Hydrochloride Tablet Market by Manufacturers
- 3.1 Global Donepezil Hydrochloride Tablet Revenue by Manufacturers (2021-2026)
- 3.2 Global Donepezil Hydrochloride Tablet Sales by Manufacturers (2021-2026)
- 3.3 Global Donepezil Hydrochloride Tablet Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Donepezil Hydrochloride Tablet Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Donepezil Hydrochloride Tablet Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Donepezil Hydrochloride Tablet Manufacturers, Product Type & Application
- 3.7 Global Donepezil Hydrochloride Tablet Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Donepezil Hydrochloride Tablet Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Donepezil Hydrochloride Tablet Players Market Share by Revenue in 2025
- 3.8.3 2025 Donepezil Hydrochloride Tablet Tier 1, Tier 2, and Tier 3
4 Donepezil Hydrochloride Tablet Market by Type
- 4.1 Donepezil Hydrochloride Tablet Type Introduction
- 4.1.1 5 mg/tablet
- 4.1.2 10 mg/tablet
- 4.2 Global Donepezil Hydrochloride Tablet Sales by Type
- 4.2.1 Global Donepezil Hydrochloride Tablet Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Donepezil Hydrochloride Tablet Sales by Type (2021-2032)
- 4.2.3 Global Donepezil Hydrochloride Tablet Sales Market Share by Type (2021-2032)
- 4.3 Global Donepezil Hydrochloride Tablet Revenue by Type
- 4.3.1 Global Donepezil Hydrochloride Tablet Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Donepezil Hydrochloride Tablet Revenue by Type (2021-2032)
- 4.3.3 Global Donepezil Hydrochloride Tablet Revenue Market Share by Type (2021-2032)
5 Donepezil Hydrochloride Tablet Market by Application
- 5.1 Donepezil Hydrochloride Tablet Application Introduction
- 5.1.1 Hospitals
- 5.1.2 Drugstores
- 5.1.3 Others
- 5.2 Global Donepezil Hydrochloride Tablet Sales by Application
- 5.2.1 Global Donepezil Hydrochloride Tablet Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Donepezil Hydrochloride Tablet Sales by Application (2021-2032)
- 5.2.3 Global Donepezil Hydrochloride Tablet Sales Market Share by Application (2021-2032)
- 5.3 Global Donepezil Hydrochloride Tablet Revenue by Application
- 5.3.1 Global Donepezil Hydrochloride Tablet Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Donepezil Hydrochloride Tablet Revenue by Application (2021-2032)
- 5.3.3 Global Donepezil Hydrochloride Tablet Revenue Market Share by Application (2021-2032)
6 Global Donepezil Hydrochloride Tablet Sales by Region
- 6.1 Global Donepezil Hydrochloride Tablet Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Donepezil Hydrochloride Tablet Sales by Region (2021-2032)
- 6.2.1 Global Donepezil Hydrochloride Tablet Sales by Region (2021-2026)
- 6.2.2 Global Donepezil Hydrochloride Tablet Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Donepezil Hydrochloride Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Donepezil Hydrochloride Tablet Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Donepezil Hydrochloride Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Donepezil Hydrochloride Tablet Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Donepezil Hydrochloride Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Donepezil Hydrochloride Tablet Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Donepezil Hydrochloride Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Donepezil Hydrochloride Tablet Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Donepezil Hydrochloride Tablet Revenue by Region
- 7.1 Global Donepezil Hydrochloride Tablet Revenue by Region
- 7.1.1 Global Donepezil Hydrochloride Tablet Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Donepezil Hydrochloride Tablet Revenue by Region (2021-2026)
- 7.1.3 Global Donepezil Hydrochloride Tablet Revenue by Region (2027-2032)
- 7.1.4 Global Donepezil Hydrochloride Tablet Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Donepezil Hydrochloride Tablet Revenue (2021-2032)
- 7.2.2 North America Donepezil Hydrochloride Tablet Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Donepezil Hydrochloride Tablet Revenue (2021-2032)
- 7.3.2 Europe Donepezil Hydrochloride Tablet Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Donepezil Hydrochloride Tablet Revenue (2021-2032)
- 7.4.2 Asia-Pacific Donepezil Hydrochloride Tablet Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Donepezil Hydrochloride Tablet Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Donepezil Hydrochloride Tablet Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Eisai
- 8.1.1 Eisai Company Information
- 8.1.2 Eisai Business Overview
- 8.1.3 Eisai Donepezil Hydrochloride Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Eisai Donepezil Hydrochloride Tablet Product Portfolio
- 8.1.5 Eisai Recent Developments
- 8.2 Luoxin Pharmaceutical
- 8.2.1 Luoxin Pharmaceutical Company Information
- 8.2.2 Luoxin Pharmaceutical Business Overview
- 8.2.3 Luoxin Pharmaceutical Donepezil Hydrochloride Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Luoxin Pharmaceutical Donepezil Hydrochloride Tablet Product Portfolio
- 8.2.5 Luoxin Pharmaceutical Recent Developments
- 8.3 Pfizer
- 8.3.1 Pfizer Company Information
- 8.3.2 Pfizer Business Overview
- 8.3.3 Pfizer Donepezil Hydrochloride Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Pfizer Donepezil Hydrochloride Tablet Product Portfolio
- 8.3.5 Pfizer Recent Developments
- 8.4 Huahai Pharmaceutical
- 8.4.1 Huahai Pharmaceutical Company Information
- 8.4.2 Huahai Pharmaceutical Business Overview
- 8.4.3 Huahai Pharmaceutical Donepezil Hydrochloride Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Huahai Pharmaceutical Donepezil Hydrochloride Tablet Product Portfolio
- 8.4.5 Huahai Pharmaceutical Recent Developments
- 8.5 Hansoh Pharma
- 8.5.1 Hansoh Pharma Company Information
- 8.5.2 Hansoh Pharma Business Overview
- 8.5.3 Hansoh Pharma Donepezil Hydrochloride Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Hansoh Pharma Donepezil Hydrochloride Tablet Product Portfolio
- 8.5.5 Hansoh Pharma Recent Developments
- 8.6 Hisun Pharmaceutical
- 8.6.1 Hisun Pharmaceutical Company Information
- 8.6.2 Hisun Pharmaceutical Business Overview
- 8.6.3 Hisun Pharmaceutical Donepezil Hydrochloride Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Hisun Pharmaceutical Donepezil Hydrochloride Tablet Product Portfolio
- 8.6.5 Hisun Pharmaceutical Recent Developments
- 8.7 ARK PHA.LTD
- 8.7.1 ARK PHA.LTD Company Information
- 8.7.2 ARK PHA.LTD Business Overview
- 8.7.3 ARK PHA.LTD Donepezil Hydrochloride Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 ARK PHA.LTD Donepezil Hydrochloride Tablet Product Portfolio
- 8.7.5 ARK PHA.LTD Recent Developments
- 8.8 Lupin
- 8.8.1 Lupin Company Information
- 8.8.2 Lupin Business Overview
- 8.8.3 Lupin Donepezil Hydrochloride Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Lupin Donepezil Hydrochloride Tablet Product Portfolio
- 8.8.5 Lupin Recent Developments
- 8.9 Globalstar
- 8.9.1 Globalstar Company Information
- 8.9.2 Globalstar Business Overview
- 8.9.3 Globalstar Donepezil Hydrochloride Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Globalstar Donepezil Hydrochloride Tablet Product Portfolio
- 8.9.5 Globalstar Recent Developments
- 8.10 G Med Impex
- 8.10.1 G Med Impex Company Information
- 8.10.2 G Med Impex Business Overview
- 8.10.3 G Med Impex Donepezil Hydrochloride Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 G Med Impex Donepezil Hydrochloride Tablet Product Portfolio
- 8.10.5 G Med Impex Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Donepezil Hydrochloride Tablet Value Chain Analysis
- 9.1.1 Donepezil Hydrochloride Tablet Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Donepezil Hydrochloride Tablet Production Mode & Process
- 9.2 Donepezil Hydrochloride Tablet Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Donepezil Hydrochloride Tablet Distributors
- 9.2.3 Donepezil Hydrochloride Tablet Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst